Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Prevalence of Dyskinesia and OFF by 30-Minute Intervals Through the Day and Assessment of Daily Episodes of Dyskinesia and OFF: Novel Analyses of Diary Data from Gocovri Pivotal Trials.

Hauser RA, Kremens DE, Elmer LW, Kreitzman DL, Walsh RR, Johnson R, Howard R, Nguyen JT, Patni R.

J Parkinsons Dis. 2019;9(3):591-600. doi: 10.3233/JPD-181565.

2.

Author Correction to: Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson's Disease.

Elmer LW, Juncos JL, Singer C, Truong DD, Criswell SR, Parashos S, Felt L, Johnson R, Patni R.

CNS Drugs. 2018 Apr;32(4):399-400. doi: 10.1007/s40263-018-0510-z.

PMID:
29637528
3.

Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson's Disease.

Elmer LW, Juncos JL, Singer C, Truong DD, Criswell SR, Parashos S, Felt L, Johnson R, Patni R.

CNS Drugs. 2018 Apr;32(4):387-398. doi: 10.1007/s40263-018-0498-4. Erratum in: CNS Drugs. 2018 Apr 10;:.

4.

Optimizing extended-release carbidopa/levodopa in Parkinson disease: Consensus on conversion from standard therapy.

Espay AJ, Pagan FL, Walter BL, Morgan JC, Elmer LW, Waters CH, Agarwal P, Dhall R, Ondo WG, Klos KJ, Silver DE.

Neurol Clin Pract. 2017 Feb;7(1):86-93. doi: 10.1212/CPJ.0000000000000316. Review.

5.

The Efficacy Profile of Rotigotine During the Waking Hours in Patients With Advanced Parkinson's Disease: A Post Hoc Analysis.

LeWitt PA, Poewe W, Elmer LW, Asgharnejad M, Boroojerdi B, Grieger F, Bauer L.

Clin Neuropharmacol. 2016 Mar-Apr;39(2):88-93. doi: 10.1097/WNF.0000000000000133.

6.

Impact of 6-month earlier versus postponed initiation of rotigotine on long-term outcome: post hoc analysis of patients with early Parkinson's disease with mild symptom severity.

Timmermann L, Asgharnejad M, Boroojerdi B, Dohin E, Woltering F, Elmer LW.

Expert Opin Pharmacother. 2015;16(10):1423-33. doi: 10.1517/14656566.2015.1049597. Epub 2015 May 22.

PMID:
25997442
7.

A randomized study of rotigotine dose response on 'off' time in advanced Parkinson's disease.

Nicholas AP, Borgohain R, ChanĂ¡ P, Surmann E, Thompson EL, Bauer L, Whitesides J, Elmer LW; SP921 Study Investigators.

J Parkinsons Dis. 2014;4(3):361-73. doi: 10.3233/JPD-130320.

PMID:
24643203
8.

Rasagiline adjunct therapy in patients with Parkinson's disease: post hoc analyses of the PRESTO and LARGO trials.

Elmer LW.

Parkinsonism Relat Disord. 2013 Nov;19(11):930-6. doi: 10.1016/j.parkreldis.2013.06.001. Epub 2013 Jul 10.

PMID:
23849501
9.

Long-term safety and tolerability of rotigotine transdermal system in patients with early-stage idiopathic Parkinson's disease: a prospective, open-label extension study.

Elmer LW, Surmann E, Boroojerdi B, Jankovic J.

Parkinsonism Relat Disord. 2012 Jun;18(5):488-93. doi: 10.1016/j.parkreldis.2012.01.008. Epub 2012 Feb 10.

PMID:
22326237
10.

Orally disintegrating selegiline in Parkinson patients with dopamine agonist-related adverse effects.

Lyons KE, Friedman JH, Hermanowicz N, Isaacson SH, Hauser RA, Hersh BP, Silver DE, Tetrud JW, Elmer LW, Parashos SA, Struck LK, Lew MF, Pahwa R.

Clin Neuropharmacol. 2010 Jan-Feb;33(1):5-10. doi: 10.1097/WNF.0b013e3181b7926f.

PMID:
19855267
11.

The increasing role of monoamine oxidase type B inhibitors in Parkinson's disease therapy.

Elmer LW, Bertoni JM.

Expert Opin Pharmacother. 2008 Nov;9(16):2759-72. doi: 10.1517/14656566.9.16.2759 . Review.

PMID:
18937611
12.

Ropinirole 24-hour prolonged release: randomized, controlled study in advanced Parkinson disease.

Pahwa R, Stacy MA, Factor SA, Lyons KE, Stocchi F, Hersh BP, Elmer LW, Truong DD, Earl NL; EASE-PD Adjunct Study Investigators.

Neurology. 2007 Apr 3;68(14):1108-15.

PMID:
17404192
13.

Acoustic analysis of clear versus conversational speech in individuals with Parkinson disease.

Goberman AM, Elmer LW.

J Commun Disord. 2005 May-Jun;38(3):215-30. Epub 2004 Dec 15.

PMID:
15748725
14.

Cocaine induction of dopamine transporter trafficking to the plasma membrane.

Little KY, Elmer LW, Zhong H, Scheys JO, Zhang L.

Mol Pharmacol. 2002 Feb;61(2):436-45.

PMID:
11809869
15.

Sodium channels in astrocytes of rat optic nerve in situ: immuno-electron microscopic studies.

Black JA, Friedman B, Elmer LW, Waxman SG.

Glia. 1999 Oct;28(1):84. No abstract available.

PMID:
10498826
16.

Corrigendum to 'Expression and regulation of the human dopamine transporter in a neuronal cell line'

Zhang L, Elmer LW, Little KY.

Brain Res Mol Brain Res. 1998 Dec 10;63(1):205. No abstract available.

PMID:
9838119
17.

Expression and regulation of the human dopamine transporter in a neuronal cell line.

Zhang L, Elmer LW, Little KY.

Brain Res Mol Brain Res. 1998 Aug 15;59(1):66-73. Erratum in: Brain Res Mol Brain Res 1998 Dec 10;63(1):205.

PMID:
9729282
18.
19.

Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues.

Strong TV, Tagle DA, Valdes JM, Elmer LW, Boehm K, Swaroop M, Kaatz KW, Collins FS, Albin RL.

Nat Genet. 1993 Nov;5(3):259-65.

PMID:
8275091
20.

A simple non-radioactive method for diagnosis of Huntington's disease.

Valdes JM, Tagle DA, Elmer LW, Collins FS.

Hum Mol Genet. 1993 Jun;2(6):633-4. No abstract available.

PMID:
8353481
21.
22.

Immuno-ultrastructural localization of sodium channels at nodes of Ranvier and perinodal astrocytes in rat optic nerve.

Black JA, Friedman B, Waxman SG, Elmer LW, Angelides KJ.

Proc R Soc Lond B Biol Sci. 1989 Oct 23;238(1290):39-51.

PMID:
2574468
23.
24.

Distribution and lateral mobility of voltage-dependent sodium channels in neurons.

Angelides KJ, Elmer LW, Loftus D, Elson E.

J Cell Biol. 1988 Jun;106(6):1911-25. Erratum in: J Cell Biol 1989 May;108(5):preceding 2001.

25.

Physicochemical characterization of the alpha-peptide of the sodium channel from rat brain.

Elmer LW, O'Brien BJ, Nutter TJ, Angelides KJ.

Biochemistry. 1985 Dec 31;24(27):8128-37.

PMID:
2418876
26.

Functional unit size of the neurotoxin receptors on the voltage-dependent sodium channel.

Angelides KJ, Nutter TJ, Elmer LW, Kempner ES.

J Biol Chem. 1985 Mar 25;260(6):3431-9.

Supplemental Content

Loading ...
Support Center